Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of epicardial adipose tissue thickness and cardiac structure and function in early midlife: the cardiovascular risk in Young Finns Study.

European journal of preventive cardiology·2025

Same author

Fueling of a marine-terrestrial ecosystem by a major seabird colony.

Scientific reports·2020

Same author

Virome definition in cerebrospinal fluid of patients with neurological complications after hematopoietic stem cell transplantation.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2018

Same author

Music therapy supported the health-related quality of life for children undergoing haematopoietic stem cell transplants.

Acta paediatrica (Oslo, Norway : 1992)·2018

Same author

Virome characterisation from Guthrie cards in children who later developed acute lymphoblastic leukaemia.

British journal of cancer·2016

Same author

Music therapy can lower the heart rates of severely sick children.

Acta paediatrica (Oslo, Norway : 1992)·2016

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Immunizing schedules for hybridoma production.

¹Karolinska Institute and National Bacteriological Laboratory, Stockholm, Sweden.

Methods in Molecular Biology (Clifton, N.J.)

|March 5, 2011

Summary

Optimizing immunization protocols is key for successful hybridoma production. Adjusting antigen dose, presentation, and timing enhances antibody specificity and affinity, leading to more antibody-producing hybridomas.

Area of Science:

Immunology
Biotechnology

Background:

Hybridoma technology is crucial for monoclonal antibody production.
Effective immunization strategies are essential for generating high-quality antibodies.

Purpose of the Study:

To outline optimal immunization protocols for hybridoma production.
To investigate factors influencing antibody specificity and affinity.

Main Methods:

Varying antigen dose, presentation, and injection timing.
Considering antigen purity and contaminants in immunization design.
Evaluating antibody specificity and affinity post-immunization.

Main Results:

Lower antigen doses generally yield higher antibody specificity.

More Related Videos

Generation of Monoclonal Antibodies Against Natural Products

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

Laboratory Scale Production and Purification of a Therapeutic Antibody

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Related Experiment Videos

Last Updated: Jun 3, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Generation of Monoclonal Antibodies Against Natural Products

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

Laboratory Scale Production and Purification of a Therapeutic Antibody

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Prolonged immunization schedules result in higher antibody affinity.

Effective immunization directly correlates with hybridoma yield.

Conclusions:

Immunization protocol optimization is critical for successful hybridoma development.
Tailoring protocols to specific antigens and desired antibody characteristics is necessary.
Careful planning of immunization enhances the efficiency of antibody production.